COMMUNIQUÉS West-GlobeNewswire
-
Alira Health Joins PFMD Effort to Advance Patient-Centered Evidence Generation
28/04/2026 -
Emergent BioSolutions and Substipharm Biologics Announce Strategic Manufacturing Partnership to Support Japanese Encephalitis Vaccine in the United States
28/04/2026 -
Annovis Publishes Phase 2/3 Alzheimer's Trial Results in Nature Portfolio
28/04/2026 -
Leadership Team Expansion to Support the Need for Healthier Employees
28/04/2026 -
Aveanna to Participate at the Barclays 30th Annual Leveraged Finance Conference
28/04/2026 -
CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation
28/04/2026 -
Catalyst Pharmaceuticals to Report First Quarter 2026 Financial Results on May 11, 2026
28/04/2026 -
Cynet Launches New Capabilities for CyAI Engine That Improves Itself Over Time
28/04/2026 -
Novo Nordisk to present new data on Wegovy®, women with obesity and next-generation weight loss treatments at European Congress on Obesity
28/04/2026 -
Flyte Deploys Additional Vision Jets in the Northeast to Capture Surging Summer Demand
28/04/2026 -
VivoSim Platform Predicts Gastrointestinal Toxicity (Diarrhea) in an AI Model Trained on Human Intestinal Model Results – Without Animal Testing
28/04/2026 -
Biomolecular Holdings Announces Issuance of Foundational Patents for Revolutionary Tetrahedral Antibody Technology
28/04/2026 -
Juniper Biosciences Announces Strategic Collaboration with leading global cancer center on F-MISO (JBS-003): A First-in-Class Precision Diagnostic Poised to Revolutionize Head and Neck Cancer Treatment
28/04/2026 -
Artelo Biosciences Announces Strategic Collaboration with Artificial Intelligence (AI) Leader ScienceMachine Highlighting New Expansion Opportunities and Insights for FABP5 Inhibitor Development
28/04/2026 -
Legend Biotech to Host Investor Conference Call on First Quarter 2026 Results
28/04/2026 -
Kestrel Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of KST-6051, a Potential Best-in-Class Pan-KRAS Inhibitor, in Patients with KRAS-driven Malignancies
28/04/2026 -
Nautilus Biotechnology Reports First Quarter 2026 Financial Results
28/04/2026 -
Daxor Leverages MedAxiom CV Transforum Spring’26 to Accelerate Commercial Adoption of Blood Volume Analysis
28/04/2026 -
Playground Pediatrics Expands Pediatric Access Across Four States
28/04/2026
Pages